REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...
An Aston University researcher has developed a new technique using light which could revolutionize non-invasive medical diagnostics and optical communication. The research showcases how a type of ...
CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback